Coming Soon

Touchlight Genetics specializes in the development of proprietary methods for the production of therapeutic DNA. The company focuses on enabling the creation of next-generation medicines and offers services for DNA manufacturing and optimization.
Public Funding Received
Development and implementation of a next-generation commercial gene therapy manufacturing platform
Collaborative R&D
2024-03-01
Utilising dbDNA for enhanced AAV Manufacture, Performance & Cost: Enabling the Next Generation of UK-based Advanced Therapies Innovators
Collaborative R&D
2023-11-01
Enabling gene therapy through the manufacture of a novel circular single-stranded CRISPR editing template
Collaborative R&D
2018-03-01
Novel production process for a highly potent recombinant protein using doggybone DNA (dbDNA) vector and cell free expression technology
Collaborative R&D
2017-11-01
DNA templated compoud semiconductor nanowire sensors
Collaborative R&D
2016-07-01
Next generation DNA constructs for the rapid and safe manufacture of AAV vectors for Regenerative Gene Therapy
Collaborative R&D
2014-07-01
Engineering Promoters for Specific Antigen Expression in a Synthetic DNA Vaccine Construct
Collaborative R&D
2012-12-01
The University of Birmingham And Touchlight Genetics Limited
Knowledge Transfer Partnership